Skip to content
Aperlena
Language:

Germany - Pharmaceuticals - Discount agreements under § 130a(8) SGB V within Open-House procedures

Original Deutschland - Arzneimittel - Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

Open Contract notice 465 days left
Watch this tender

Deadline 5 Jan. If it moves, an email when the register sees it. A correction: the same email. Your plan: decide by 22 Dec, questions by 22 Dec, draft by 29 Dec. Log in

  1. Published
  2. Today
  3. Deadline open for 706 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 17 different companies have won the last 18 comparable contracts from this buyer over 5 years. This is a genuinely open race.

0%
Expected final price vs the published estimate

Based on 18 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

IKK classic, a German statutory health insurance fund, will conclude non-exclusive discount agreements with all interested and suitable pharmaceutical companies for various active substances and combinations under § 130a(8) SGB V, based on identical, non-negotiable conditions (Open-House procedure). The contract period runs from 01.03.2026 to 29.02.2028. The earliest contract start is 01.03.2026 if the signed contract and all required documents are received by 05.02.2026. Later: documents received by the 5th of a month mean a contract start on the 1st of the following month; after the 5th, the 1st of the month after next. Accession is possible anytime until 05.01.2028.

Description

Die IKK classic gibt hiermit bekannt, dass sie mit allen interessierten und geeigneten pharmazeutischen Unternehmen im Zeitraum vom 01.03.2026 bis zum 29.02.2028 zu verschiedenen Wirkstoffen und Wirkstoffkombinationen nicht-exklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu gleichen, nicht verhandelbaren Bedingungen abschließen wird. Frühester Vertragsbeginn ist der 01.03.2026, sofern der unterschriebene Vertrag und alle nötigen Nachweise, Eigenerklärungen und Unterlagen bis zum 05.02.2026 bei der IKK classic eingehen. Danach gilt: Bei Eingang der Unterlagen bis zum 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des Folgemonats Vertragsbeginn. Bei Eingang der Unterlagen nach dem 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des übernächsten Folgemonats Vertragsbeginn. Ein Beitritt zur Vereinbarung ist im angegebenen Zeitraum jederzeit möglich, spätestens jedoch bis zum 05.01.2028. Weitere Angaben siehe Pkt. VI.3). Abobotulinumtoxin; ATC-Code: M03AX21 (ADV); M03AX01 (WHO); Atropin; ATC-Code: S01FA01; Azelainsäure; ATC-Code: D10AX03; Bexaroten; ATC-Code: L01XF03; Buserelin; ATC-Code:L02AE01; Choriongonadotropin alfa; ATC-Code: G03GA08; Clindamycin; ATC-Code: G01AA10; Cyanocobalamin; Injektionslösung; ATC-Code: B03BA01; Duloxetin; Wirkstärke 45 mg, 90 mg und 120 mg; Packungsgröße: 98 HKM (N3); ATC-Code: N06AX21; Estradiol 0,5-Wasser; Gel; Wirkstärke 0,62 mg; ATC-Code: G03CA03; Estradiol 0,5-Wasser; Transdermales Spray; ATC-Code: G03CA03; Everolimus; bei Renalem Angiomyolipom assoziiert mit tuberöser Sklerose oder bei Subependymalem Riesenzellastrozytom im Zusammenhang mit tuberöser Sklerose; ATC-Code: L01EG02; Follitropin delta; ATC-Code: G03GA10; Goserelin; ATC-Code: L02AE03; Lösungen zur parenteralen Ernährung - Kombinationen; ATC-Code: B05BA10; Lutropin alfa und Follitropin alfa; ATC-Code: G03GA21 (ADV); G03GA30 (WHO); Mebendazol; ATC-Code: P02CA01; Mebeverin; Retardkapseln; ATC-Code: A03AA04; Menotropin; ATC-Code: G03GA02; Methylprednisolon; Tabletten; ATC-Code: H02AB04; Natriumphenylbutyrat; ATC-Code: A16AX03; Nystatin und Zinkoxid; ATC-Code: D01AA91 (ADV); D01AA (WHO); Olaparib; ATC-Code: L01XK01; Perindopril arginin und Indapamid; Filmtabletten, Tabletten; Packungsgröße: 90 FTA oder TAB; ATC-Code: C09BA54 (ADV); C09BA04 (WHO); Rilpivirin; Filmtabletten; ATC-Code: J05AG05; Rotigotin; Pflaster transdermal; Packungsgröße: 8-12 PFT sowie 95-100 PFT; ATC-Code: N04BC09; Sultiam; ATC-Code: N03AX03; Testosteron; Gel; ATC-Code: G03BA03; Timolol; Augentropfen in Pipetten; ATC-Code: S01ED01; Tinzaparin; ATC-Code: B01AB10; Treprostinil; ATC-Code: B01AC21; Lanreotid; ATC-Code: H01CB03

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

16 open tenders right now

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Dexcel Pharma GmbH; Glenmark Arzneimittel GmbH; neuraxpharm Arzneimittel GmbH; Zentiva Pharma GmbH; BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, 2 €449.2M Jul 2026
BG ALIUD STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Zentiva Pharma GmbH; 089Pharm GmbH; betapharm Arzneimittel GmbH; PUREN Pharma Gm 1 €12.5M Jan 2026
Abacus Medicine A/S 1 n/a Jan 2026
Bencard Allergie GmbH 1 n/a May 2026
EurimPharm Arzneimittel GmbH 1 n/a Jul 2026

Based on 18 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 17 comparable contracts this buyer awarded in this sector over the last 4 years.

€1
Lower quartile
€1
Median award
€1
Upper quartile

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    • Submission deadline: Moved 1 day EARLIER: now January 5, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.
  2. Act now
    • Submission deadline: Moved 1 day EARLIER: now January 5, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,074,256
9,826 open across Europe right now
Buyer track record on Aperlena
69 notices tracked · 28 awarded
€462,107,931 in awarded contracts

Never miss a tender like this

76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

465 days left

Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close